Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Nov 2022 for Kezar Life Sciences, Inc., €24k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
John Franklin Fowler: trading record in brief
John Franklin Fowler is a declared insider of Kezar Life Sciences, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 14 December 2021 to 10 November 2022, the count stands at 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 14 November 2022, reports an option exercise of €24k in Kezar Life Sciences, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John Franklin Fowler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
27,000 shares@ US$0.9066.4% of flowCommon StockSEC:0001209191-22-056479:0
7,700 shares@ US$0.9020.2% of flowCommon StockSEC:0001209191-21-069814:0
2 of 2 declarations
